STOCK TITAN

Zimmer Biomet exec awarded 10,334 RSUs

Zimmer Biomet Group Pres, EMEA Wilfred Van Zuilen reported equity compensation activity.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zimmer Biomet Group Pres, EMEA Wilfred Van Zuilen reported equity compensation activity. On February 20, 2026, 2,451 restricted stock units vested into the same number of common shares, and 638 shares were withheld to cover tax obligations. He also received a new award of 10,334 restricted stock units that vest annually over three years starting February 20, 2027. After these transactions, he directly holds 12,784 restricted stock units and 23,455 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider VAN ZUILEN WILFRED
Role Group Pres, EMEA
Type Security Shares Price Value
Exercise Restricted Stock Units 2,451 $0.00 $0.00
Grant/Award Restricted Stock Units 10,334 $0.00 $0.00
Exercise Common Stock 2,451 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 638 $98.62 $63K
Holdings After Transaction: Restricted Stock Units — 12,784 contracts (Direct); Common Stock — 23,455 shares (Direct)
Footnotes (4)
  1. F1. Includes 169 shares acquired under the Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025.
  2. F2. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
  3. F3. Each RSU represents a contingent right to receive one share of Company common stock.
  4. F4. Vests annually over three years in increments of one-third each year, commencing February 20, 2027.
RSUs vested 2451 units Restricted Stock Units converting to common stock on February 20, 2026
RSU grant 10334 units New restricted stock unit award on February 20, 2026
Tax shares withheld 638 shares at $98.62 per share Common stock withheld to satisfy tax obligations on RSU vesting
Post-transaction RSUs 12,784 units Direct restricted stock unit holdings after reported transactions
Post-transaction common shares 23,455 shares Direct common stock holdings after reported transactions
ESPP shares acquired 169 shares Shares acquired under the Employee Stock Purchase Plan in 2025
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"Includes 169 shares acquired under the Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
tax withholding obligations financial
"to satisfy tax withholding obligations on the vesting of RSUs"
vests annually over three years financial
"Vests annually over three years in increments of one-third each year"

FAQ

What insider transactions did Wilfred Van Zuilen report for ZBH on February 20, 2026?

Wilfred Van Zuilen reported 2,451 RSUs vesting into common stock, a tax-related disposition of 638 shares, and a new grant of 10,334 RSUs. These transactions reflect routine equity compensation activity rather than open-market buying or selling.

How many restricted stock units vested for Wilfred Van Zuilen at Zimmer Biomet (ZBH)?

On February 20, 2026, 2,451 restricted stock units vested for Wilfred Van Zuilen, delivering the same number of Zimmer Biomet common shares. This vesting arose from prior equity awards as part of his compensation package.

What new RSU award did Wilfred Van Zuilen receive from Zimmer Biomet (ZBH)?

Wilfred Van Zuilen received a new grant of 10,334 restricted stock units. According to the disclosure, this award vests annually in three equal installments, beginning on February 20, 2027, tying a portion of his compensation to future service.

How many Zimmer Biomet (ZBH) shares were withheld for taxes in this Form 4?

The filing shows 638 shares of Zimmer Biomet common stock were withheld to satisfy tax obligations related to the RSU vesting. This is a non-market disposition typically used to cover withholding taxes without requiring a separate cash payment.

What are Wilfred Van Zuilen’s Zimmer Biomet (ZBH) holdings after these transactions?

After the reported transactions, Wilfred Van Zuilen directly holds 12,784 restricted stock units and 23,455 shares of Zimmer Biomet common stock. These positions reflect his remaining unvested equity awards and current direct share ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VAN ZUILEN WILFRED

(Last) (First) (Middle)
345 E. MAIN STREET

(Street)
WARSAW IN 46580

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Group Pres, EMEA
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2026 M 2,451 A $0 24,093(1) D
Common Stock 02/20/2026 F 638(2) D $98.62 23,455 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 02/20/2026 M 2,451 02/20/2026 02/20/2026 Common Stock 2,451 $0 2,450 D
Restricted Stock Units (3) 02/20/2026 A 10,334 (4) (4) Common Stock 10,334 $0 10,334 D
Explanation of Responses:
1. Includes 169 shares acquired under the Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025.
2. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
3. Each RSU represents a contingent right to receive one share of Company common stock.
4. Vests annually over three years in increments of one-third each year, commencing February 20, 2027.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Wilhelmus van Zuilen (power of attorney previously filed) 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Keep reading